X‐Linked Sideroblastic Anaemia Caused by Intronic <i>ALAS2</i> Variant Resulting in Highly Variable Expressive Phenotype in Male Siblings, a Case Report

X-linked sideroblastic anaemia (XLSA) is a rare hereditary disorder caused by mutations in the <i>ALAS2</i> gene, essential for haem biosynthesis. We report two male siblings, the first of whom developed severe microcytic hypochromic anaemia requiring regular transfusions, iron chelation and an allogeneic bone marrow transplant, while his brother displayed only mild microcytic hypochromic indices without anaemia. Initial genetic screening did not identify a pathogenic variant. However, duo exome sequencing later revealed an intronic <i>ALAS2</i> mutation, initially categorised as of uncertain significance and subsequently reclassified as pathogenic. This case underscores the diagnostic challenges posed by intronic mutations and the highly variable expressivity of XLSA, even among siblings. <b>Trial Registration</b>: The authors have confirmed clinical trial registration is not needed for this submission.

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2025-05-19
DOI
https://doi.org/10.1002/jha2.70060
Primary Topic
Porphyrin Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

X‐Linked Sideroblastic Anaemia Caused by Intronic ALAS2 Variant Resulting in Highly Variable Expressive Phenotype in Male Siblings, a Case Report

Kerrie Sweeney, Aaron Niblock, James A. O’Connor, Caoimhe McKenna et al.
eJHaem
Porphyrin Metabolism and Disorders
article

X‐Linked Sideroblastic Anaemia Caused by Intronic ALAS2 Variant Resulting in Highly Variable Expressive Phenotype in Male Siblings, a Case Report

Kerrie Sweeney, Aaron Niblock, James A. O’Connor, Caoimhe McKenna, Niall Mannion
article en

Abstract

X-linked sideroblastic anaemia (XLSA) is a rare hereditary disorder caused by mutations in the <i>ALAS2</i> gene, essential for haem biosynthesis. We report two male siblings, the first of whom developed severe microcytic hypochromic anaemia requiring regular transfusions, iron chelation and an allogeneic bone marrow transplant, while his brother displayed only mild microcytic hypochromic indices without anaemia. Initial genetic screening did not identify a pathogenic variant. However, duo exome sequencing later revealed an intronic <i>ALAS2</i> mutation, initially categorised as of uncertain significance and subsequently reclassified as pathogenic. This case underscores the diagnostic challenges posed by intronic mutations and the highly variable expressivity of XLSA, even among siblings. <b>Trial Registration</b>: The authors have confirmed clinical trial registration is not needed for this submission.

eJHaemVol. 6(3)
University of Ulster (GB), Antrim Area Hospital (GB)
Good health and well-being
Openalex Percentile: Top 90%
Porphyrin Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

X‐Linked Sideroblastic Anaemia Caused by Intronic <i>ALAS2</i> Variant Resulting in Highly Variable Expressive Phenotype in Male Siblings, a Case Report — Kerrie Sweeney, Aaron Niblock, et al. · eJHaem (2025) | TGRS Research Map | TGRS